BCG
Binah Capital Group, Inc.
There isn't enough reported data to score BCG yet.
GS
The Goldman Sachs Group, Inc.
GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
BCG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
BCG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCG.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
BCG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.3x | $1.10 | — |
| Cheap | 8x | $1.67 | +52% |
| Fair | 15x | $3.25 | +196% |
| Expensive | 76x | $16.04 | +1358% |
Historical ranges are pointers, not guarantees.
BCG has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
BCG Forward outlook
There aren't enough analyst estimates for BCG to show an outlook.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
BCG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.21 | +600% |
| Q2 2026 | $0.16 | +$0.28 |
| Q1 2026 | $0.12 | +$0.24 |
| Q4 2025 | $0.09 | +$0.41 |
| Q3 2025 | $0.03 | +$0.33 |
| Q2 2025 | -$0.12 | +$0.09 |
| Q1 2025 | -$0.12 | +$0.05 |
| Q4 2024 | -$0.32 | -900% |
BCG's earnings per share have fallen from their peak: $0.21 over the past year, against $0.36 in mid-2022.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over BCG on earnings, with more consistent year-over-year improvement.
BCG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.6M | +9.4% |
| Q2 2026 | $46.5M | +12% |
| Q1 2026 | $48.7M | -0.5% |
| Q4 2025 | $50.5M | +13% |
| Q3 2025 | $46.2M | +9.5% |
| Q2 2025 | $41.5M | +2.1% |
| Q1 2025 | $48.9M | +18% |
| Q4 2024 | $44.6M | +13% |
BCG's revenue is growing: $51M last quarter, up 9.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8% | +3.8 points |
| Q2 2026 | 0.9% | +2.3 points |
| Q1 2026 | 5.5% | +2.5 points |
| Q4 2025 | -0.5% | +0.8 points |
| Q3 2025 | 4.2% | +5.7 points |
| Q2 2025 | -1.4% | -0.1 points |
| Q1 2025 | 3% | +6.5 points |
| Q4 2024 | -1.3% | -0.8 points |
BCG's operating margin was 8% last quarter, up 3.8 points from the same quarter a year ago, near the top of its range since 2021.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over BCG on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS has the edge over BCG on profitability, with a higher operating margin.
BCG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1M | +246% |
| Q2 2026 | $1.1M | +1651% |
| Q1 2026 | $527K | -50% |
| Q4 2025 | $3.1M | +79% |
| Q3 2025 | $884K | +$1.2M |
| Q2 2025 | $63K | -94% |
| Q1 2025 | $1M | +$4.2M |
| Q4 2024 | $1.7M | -36% |
BCG has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
BCG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +2% | +340K shares |
| 3 years | +11% | +1.8M shares |
| 5 years | +19% | +2.7M shares |
BCG has 17M diluted shares, up 2% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | $691 |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $102.9M |
| Q1 2022 | — |
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over BCG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
BCG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -1.6x | Net Cash |
| Q3 2025 | -3.4x | Net Cash |
| Q1 2025 | -61.3x | Net Cash |
| Q2 2024 | -3.0x | Net Cash |
| Q1 2024 | -0.3x | Net Cash |
BCG has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like BCG.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over BCG on leverage, with a lower net debt burden relative to earnings.
BCG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 20.7 | Neutral |
BCG's weekly RSI is 37 (neutral) and its Stochastic is 21 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
BCG PE vs Financial Services Sector
| Metric | BCG | Sector median | Relative |
|---|---|---|---|
| PE | 5.3x | 13x | 59% below |
| PE % | 0 | 31 | 31 pts below |
BCG has the edge over GS on valuation relative to its sector.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
BCG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.07 | 2.8% above |
| 20 week MA | $1.27 | 13% below |
| 50 week MA | $1.76 | 37% below |
| 100 week MA | $1.94 | 43% below |
GS has stronger trend alignment. BCG is above 1 of 4 weekly averages versus GS above 3 of 5.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
BCG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $13.0 | $2.90 | -78% |
| 2025 | $2.90 | $2.39 | -18% |
| 2026 YTD | $2.39 | $1.10 | -54% |
BCG has finished every year since 2024 lower, and it's down 54% so far in 2026.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has the edge over BCG on returns for 2026, with the stronger performance.